Drugs / ConM SOSIP.v7
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05208125 | Mar 2022 | HIV infectious disease | IrsiCaixa | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ConM SOSIP.v7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05208125 ↗ |
| Modality | Vaccine | “Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine” NCT05208125 ↗ |